134 related articles for article (PubMed ID: 19171122)
1. Targeted deletion of hepatocyte Ikkbeta confers growth advantages.
Koch KS; Maeda S; He G; Karin M; Leffert HL
Biochem Biophys Res Commun; 2009 Mar; 380(2):349-54. PubMed ID: 19171122
[TBL] [Abstract][Full Text] [Related]
2. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.
Sakurai T; Maeda S; Chang L; Karin M
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10544-51. PubMed ID: 16807293
[TBL] [Abstract][Full Text] [Related]
3. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.
Maeda S; Kamata H; Luo JL; Leffert H; Karin M
Cell; 2005 Jul; 121(7):977-90. PubMed ID: 15989949
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific inhibitor-of-kappaB-kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration.
Malato Y; Sander LE; Liedtke C; Al-Masaoudi M; Tacke F; Trautwein C; Beraza N
Hepatology; 2008 Jun; 47(6):2036-50. PubMed ID: 18393321
[TBL] [Abstract][Full Text] [Related]
5. Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes.
Vacca M; Murzilli S; Salvatore L; Di Tullio G; D'Orazio A; Lo Sasso G; Graziano G; Pinzani M; Chieppa M; Mariani-Costantini R; Palasciano G; Moschetta A
Gastroenterology; 2013 Jun; 144(7):1518-1529.e3. PubMed ID: 23462179
[TBL] [Abstract][Full Text] [Related]
6. High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer.
Jiang R; Xia Y; Li J; Deng L; Zhao L; Shi J; Wang X; Sun B
Int J Cancer; 2010 Mar; 126(5):1263-74. PubMed ID: 19728335
[TBL] [Abstract][Full Text] [Related]
7. The transforming growth factor-α and cyclin D1 genes are direct targets of β-catenin signaling in hepatocyte proliferation.
Torre C; Benhamouche S; Mitchell C; Godard C; Veber P; Letourneur F; Cagnard N; Jacques S; Finzi L; Perret C; Colnot S
J Hepatol; 2011 Jul; 55(1):86-95. PubMed ID: 21145869
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.
He G; Yu GY; Temkin V; Ogata H; Kuntzen C; Sakurai T; Sieghart W; Peck-Radosavljevic M; Leffert HL; Karin M
Cancer Cell; 2010 Mar; 17(3):286-97. PubMed ID: 20227042
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes.
Ouyang W; Ma Q; Li J; Zhang D; Liu ZG; Rustgi AK; Huang C
Cancer Res; 2005 Oct; 65(20):9287-93. PubMed ID: 16230390
[TBL] [Abstract][Full Text] [Related]
11. Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A.
Chen L; Zeng Y; Yang H; Lee TD; French SW; Corrales FJ; García-Trevijano ER; Avila MA; Mato JM; Lu SC
FASEB J; 2004 May; 18(7):914-6. PubMed ID: 15033934
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.
Yeganeh M; Gui Y; Kandhi R; Bobbala D; Tobelaim WS; Saucier C; Yoshimura A; Ferbeyre G; Ramanathan S; Ilangumaran S
Oncogene; 2016 Aug; 35(32):4200-11. PubMed ID: 26725321
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents.
Walesky C; Edwards G; Borude P; Gunewardena S; O'Neil M; Yoo B; Apte U
Hepatology; 2013 Jun; 57(6):2480-90. PubMed ID: 23315968
[TBL] [Abstract][Full Text] [Related]
14. Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis.
Kong B; Zhu Y; Li G; Williams JA; Buckley K; Tawfik O; Luyendyk JP; Guo GL
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(5):G295-302. PubMed ID: 26744468
[TBL] [Abstract][Full Text] [Related]
15. Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration.
Nozaki Y; Hikita H; Tanaka S; Fukumoto K; Urabe M; Sato K; Myojin Y; Doi A; Murai K; Sakane S; Saito Y; Kodama T; Sakamori R; Tatsumi T; Takehara T
Sci Rep; 2021 Feb; 11(1):3363. PubMed ID: 33564095
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D3 up-regulated protein 1 deficiency accelerates liver regeneration after partial hepatectomy in mice.
Kwon HJ; Won YS; Yoon YD; Yoon WK; Nam KH; Choi IP; Kim DY; Kim HC
J Hepatol; 2011 Jun; 54(6):1168-76. PubMed ID: 21145821
[TBL] [Abstract][Full Text] [Related]
17. Ectopic expression of CD74 in Ikkβ-deleted mouse hepatocytes.
Koch KS; Leffert HL
Acta Histochem; 2011 Jul; 113(4):428-35. PubMed ID: 20569972
[TBL] [Abstract][Full Text] [Related]
18. Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.
Shang N; Bank T; Ding X; Breslin P; Li J; Shi B; Qiu W
Cell Death Dis; 2018 May; 9(5):558. PubMed ID: 29752472
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of hepatocyte nuclear factor 6 stimulates hepatocyte proliferation during mouse liver regeneration.
Tan Y; Yoshida Y; Hughes DE; Costa RH
Gastroenterology; 2006 Apr; 130(4):1283-300. PubMed ID: 16618419
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice.
Kuboki S; Shin T; Huber N; Eismann T; Galloway E; Schuster R; Blanchard J; Edwards MJ; Lentsch AB
Hepatology; 2008 Oct; 48(4):1213-23. PubMed ID: 18688883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
